Evidence map›Paper›PMID 41097095›Full record

ReviewInternational journal of molecular sciences2025

Viral Metagenomic Next-Generation Sequencing for One Health Discovery and Surveillance of (Re)Emerging Viruses: A Deep Review.

Tristan Russell, Elisa Formiconi, Mícheál Casey, Maíre McElroy, Patrick W G Mallon, Virginie W Gautier

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tristan RussellUCD Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, D04 E1W1 Dublin, Ireland.ORCID 0000-0002-1962-0651
Elisa FormiconiUCD Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, D04 E1W1 Dublin, Ireland.
Mícheál CaseyRegional Veterinary Laboratories (RVL) Division, Department of Agriculture, Food and the Marine, Agriculture House, Backweston, T12 XD51 Dublin, Ireland.
Maíre McElroyDepartment of Agriculture, Food, and the Marine Laboratories, Backweston, Celbridge, W23 VW2C Kildare, Ireland.
Patrick W G MallonUCD Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, D04 E1W1 Dublin, Ireland.
Virginie W GautierUCD Centre for Experimental Pathogen Host Research (CEPHR), University College Dublin, D04 E1W1 Dublin, Ireland.ORCID 0000-0003-1862-2644

Funding

European Commission 101132970
6 · The paper itself

Abstract

Viral metagenomic next-generation sequencing (vmNGS) has transformed our capacity for the untargeted detection and characterisation of (re)emerging zoonotic viruses, surpassing the limitations of traditional targeted diagnostics. In this review, we critically evaluate the current landscape of vmNGS, highlighting its integration within the One Health paradigm and its application to the surveillance and discovery of (re)emerging viruses at the human-animal-environment interface. We provide a detailed overview of vmNGS workflows including sample selection, nucleic acid extraction, host depletion, virus enrichment, sequencing platforms, and bioinformatic pipelines, all tailored to maximise sensitivity and specificity for diverse sample types. Through selected case studies, including SARS-CoV-2, mpox, Zika virus, and a novel henipavirus, we illustrate the impact of vmNGS in outbreak detection, genomic surveillance, molecular epidemiology, and the development of diagnostics and vaccines. The review further examines the relative strengths and limitations of vmNGS in both passive and active surveillance, addressing barriers such as cost, infrastructure requirements, and the need for interdisciplinary collaboration. By integrating molecular, ecological, and public health perspectives, vmNGS stands as a central tool for early warning, comprehensive monitoring, and informed intervention against (re)emerging viral threats, underscoring its critical role in global pandemic preparedness and zoonotic disease control.

Indexed as

Communicable Diseases, EmergingHigh-Throughput Nucleotide SequencingMetagenomicsVirusesAnimalsGenome, ViralHumansOne HealthSARS-CoV-2Zoonosesmetagenomic next-generation sequencingone healthpandemic preparedness(re)emerging virusessurveillance

Identifiers

PMID41097095
PMCPMC12524960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.